logo-loader
viewCellmid Limited

Cellmid appoints Advangen USA CEO to help expand distribution

Brian McGee has been instrumental in securing new partnerships, including the recently announced deals with Beauty Collection, Macys.com, Rymax and Dermstore, which are expected to deliver material growth in the US business.

Cellmid Limited - Cellmid appoints CEO to Advangen USA to expand distribution
Cellmid is an Australian life sciences company with a consumer health business and biotech assets in development

Cellmid Ltd (ASX:CDY) has appointed senior executive Brian McGee as chief executive officer of its wholly-owned USA subsidiary Advangen LLC effective from November 1.

McGee has 30 years’ in sales, marketing and operations in the beauty and hair care industry bringing a wealth of knowledge and broad industry contacts in the USA.

His mandate in the new role is to increase distribution and sales of Cellmid's prestige évolis® Professional products in the USA and to embed operations including manufacture, warehousing and brand-development.

Cellmid's chief executive officer Maria Halasz said: “We welcome Brian to the senior leadership team and we are confident that his extensive experience in beauty retailing will ensure the long-term growth of the évolis® brand in the USA.

“His knowledge of the market and broad industry contacts have made a significant impact on the business.”

Previous experience

Throughout his career, McGee gained experience in managing sales teams and the operations of some iconic haircare brands including Aveda and as chief operating officer, pioneered the omnichannel retailing of hair colour brand dpHUE.

He has worked for the évolis® Professional brand as a consultant since May 2019 and has been instrumental in broadening the company’s existing retail relationships as well as securing new partnerships, which are expected to deliver material growth in the US business in the coming months.

“Excited to be joining" team

McGee said: “I am very excited to be joining the senior leadership team of the company.

“Having worked in the haircare sector for many years, I truly appreciate the market potential for the évolis products and the significant opportunities in bringing the brand to a wider USA customer base.”

Quick facts: Cellmid Limited

Price: 0.245 AUD

ASX:CDY
Market: ASX
Market Cap: $23.67 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Cellmid Limited named herein, including the promotion by the Company of Cellmid Limited in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Cellmid makes key retail collaborations and continues to kick strategic goals

Cellmid Limited (ASX:CDY) chief executive officer and managing director Maria Halasz updates Proactive on a number of recent key announcements, including a new collaboration with a major retail chain in Europe, a new agreement to sell Evolis in 400 Priceline pharmacies and signing up with the...

3 weeks, 3 days ago

2 min read